Site Map
Product Pages Catalogue Numbers 1601 - 1700
| Cat. No. | Product Name & Pharmacological Action |
|---|---|
| 1601 | Pep1-TGL |
| GluR1 subunit C-terminus peptide analogue | |
| 1602 | Pep1-AGL |
| Analogue of Cat. No. 1601 | |
| 1603 | NKH 477 |
| Water-soluble adenylyl cyclase activator | |
| 1604 | Urocortin (human) |
| Endogenous CRF agonist | |
| 1605 | Urocortin (rat) |
| Endogenous CRF agonist | |
| 1606 | Astressin |
| Potent CRF receptor antagonist | |
| 1607 | CRF (6-33) |
| CRF-binding protein inhibitor | |
| 1608 | Stressin I |
| CRF1 agonist | |
| 1609 | Sauvagine |
| CRF agonist | |
| 1610 | Rottlerin |
| Reported PKCδ inhibitor | |
| 1611 | Lamotrigine |
| Inhibits glutamate release. Anticonvulsant | |
| 1612 | SB 269970 hydrochloride |
| Potent selective 5-HT7 antagonist. Brain penetrant | |
| 1614 | SB 431542 |
| Potent, selective inhibitor of TGF-β receptor ALK5, and ALK4 and 7 | |
| 1615 | SB 366791 |
| Potent, selective, competitive TRPV1 (VR1) antagonist | |
| 1616 | SB 216763 |
| Potent selective GSK-3 inhibitor | |
| 1617 | SB 415286 |
| Potent selective GSK-3 inhibitor | |
| 1618 | Peptide YY (3-36) |
| Selective Y2 receptor agonist | |
| 1619 | [Orn8]-Urotensin II |
| Urotensin II (UT) receptor partial agonist | |
| 1620 | Alprostadil |
| Prostaglandin. Vasodilator and anti-platelet agent in vivo | |
| 1621 | Streptozocin |
| DNA alkylator; antitumour and induces diabetes | |
| 1622 | Remacemide hydrochloride |
| NMDA antagonist; blocks ion channel and allosteric modulatory site | |
| 1623 | Cyclopamine |
| Inhibitor of hedgehog (hh) signalling | |
| 1624 | 2-Methylthio-ADP trisodium salt |
| Potent agonist for P2Y1, P2Y12 and P2Y13 | |
| 1625 | DFB |
| Allosteric potentiator at mGlu5 | |
| 1626 | Calphostin C |
| Potent, selective and photo-dependent PKC inhibitor | |
| 1628 | NPC 15437 dihydrochloride |
| Selective protein kinase C inhibitor | |
| 1632 | MEN 10376 |
| Potent, selective NK2 antagonist | |
| 1633 | MEN 10627 |
| Potent, selective NK2 antagonist | |
| 1634 | Y-29794 oxalate |
| Prolyl endopeptidase inhibitor | |
| 1635 | RP 67580 |
| Potent and selective NK1 antagonist | |
| 1636 | IEM 1460 |
| Open-channel blocker of AMPA currents; selective for non-GluR2-containing receptors | |
| 1638 | U 18666A |
| Inhibitor of hedgehog (hh) signalling. Also inhibits cholesterol synthesis | |
| 1639 | AY 9944 dihydrochloride |
| Inhibitor of hedgehog (hh) signalling. Inhibits D7-dehydrocholesterol reductase | |
| 1640 | [bAla8]-Neurokinin A(4-10) |
| NK2 agonist | |
| 1641 | OLDA |
| Potent, selective endogenous TRPV1 (VR1) agonist | |
| 1642 | Urotensin II (human) |
| Endogenous vasoactive agonist for the UT-II receptor | |
| 1643 | D-64131 |
| Inhibitor of tubulin polymerisation. Antitumour in vivo | |
| 1645 | 8CPT-2Me-cAMP, sodium salt |
| Selective Epac activator | |
| 1646 | Lonidamine |
| Mitochondrial hexokinase inhibitor | |
| 1650 | BAM 22P |
| Opioid receptor agonist. Also agonist at the sensory neuron specific receptor (SNSR) | |
| 1652 | Apamin |
| K+ channel blocker (small conductance, Ca2+-dependent) | |
| 1655 | O-2050 |
CB1 silent antagonist |
|
| 1657 | Ginkgolide B |
| PAF receptor antagonist | |
| 1658 | GR 125487 sulfamate |
| Potent, selective 5-HT4 antagonist. Active in vivo | |
| 1659 | Fenoldopam hydrochloride |
Selective D1-like partial agonist |
|
| 1660 | Salmeterol |
Potent β2 agonist; long acting |
|
| 1661 | SB 206553 hydrochloride |
| Potent, selective 5-HT2C/5-HT2B antagonist. Orally active | |
| 1662 | SKF 77434 hydrobromide |
Selective D1-like partial agonist |
|
| 1663 | BW 373U86 |
| Potent, selective non-peptide δ-opioid agonist | |
| 1664 | GW 1929 |
| Selective PPARγ agonist. Orally active | |
| 1667 | GR 94800 |
| Potent, selective NK2 antagonist | |
| 1668 | GR 64349 |
| Potent, selective NK2 agonist | |
| 1669 | GR 73632 |
| Potent, selective NK1 agonist | |
| 1670 | GR 82334 |
| Tachykinin NK1 receptor antagonist | |
| 1671 | PD 102807 |
Selective M4 antagonist |
|
| 1672 | RU 28318, potassium salt |
| Potent, selective mineralocorticoid receptor antagonist | |
| 1673 | Cl-HIBO |
| Subtype-selective AMPA agonist (GluR1 and GluR2) | |
| 1674 | LE 300 |
Potent and selective dopamine D1 antagonist |
|
| 1675 | YM 90709 |
| Interleukin-5 receptor antagonist | |
| 1676 | T 0156 hydrochloride |
| Highly potent, selective PDE5 inhibitor | |
| 1677 | GW 7647 |
| Highly selective, potent PPARα agonist. Orally active | |
| 1682 | PIT |
| P2Y ligand; displays mixed antagonism/potentiation | |
| 1683 | K 252a |
| Protein kinase inhibitor | |
| 1684 | TocrisolveTM 100 |
Water-soluble emulsion; negative control for Cat. Nos. 1017, 1685, 1686, 1781, 1782 and 1783 |
|
| 1685 | AM 404 (in TocrisolveTM 100) |
Anandamide transport inhibitor (in water-soluble emulsion) |
|
| 1686 | VDM 11 (in TocrisolveTM 100) |
Potent, selective anandamide transport inhibitor (in water-soluble emulsion) |
|
| 1688 | Autocamtide-2-related inhibitory peptide |
| Selective CaM kinase II inhibitor | |
| 1690 | SCH 28080 |
| H+,K+-ATPase inhibitor | |
| 1691 | NECA |
| Adenosine receptor agonist | |
| 1692 | Cilostazol |
| PDE3A inhibitor. Also adenosine uptake inhibitor | |
| 1694 | Ibudilast |
| PDE inhibitor (non-selective) | |
| 1695 | Cisapride |
| 5-HT4 agonist; stimulates intestinal ACh release | |
| 1697 | Noscapine hydrochloride |
| Tubulin inhibitor; induces apoptosis | |
| 1698 | L-655,240 |
| Potent, selective thromboxane A2/prostaglandin endoperoxide antagonist | |
| 1699 | CGS 15943 |
| Potent adenosine receptor antagonist | |
| 1700 | BIIE 0246 formate |
| Potent, selective non-peptide NPY Y2 antagonist | |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | All |
[top]